Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
17.23
-0.09 (-0.52%)
At close: Jun 26, 2026, 4:00 PM EDT
16.85
-0.38 (-2.21%)
After-hours: Jun 26, 2026, 7:17 PM EDT
Amneal Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Amneal Pharmaceuticals stock have an average target of 17, with a low estimate of 16 and a high estimate of 18. The average target predicts a decrease of -1.33% from the current stock price of 17.23.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Amneal Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 12, 2026 |
| Barclays | Barclays | Buy Maintains $16 | Buy | Maintains | $16 | -7.14% | Jun 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $17 | Buy | Maintains | $17 | -1.33% | Jun 4, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Reiterates $17 | Buy | Reiterates | $17 | -1.33% | May 28, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 23, 2026 |
Financial Forecast
Revenue This Year
3.11B
from 3.02B
Increased by 2.89%
Revenue Next Year
3.33B
from 3.11B
Increased by 7.19%
EPS This Year
0.99
from 0.83
Increased by 18.93%
EPS Next Year
1.12
from 0.99
Increased by 13.79%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.1B | 3.4B | |
| Avg | 3.1B | 3.3B | |
| Low | 3.1B | 3.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7% | 8.5% | |
| Avg | 2.9% | 7.2% | |
| Low | 2.2% | 5.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.01 | 1.20 | |
| Avg | 0.99 | 1.12 | |
| Low | 0.94 | 1.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.5% | 21.9% | |
| Avg | 18.9% | 13.8% | |
| Low | 13.1% | 5.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.